Responses
Gastroenterology and hepatology
Protocol
Etrolizumab as induction and maintenance therapy in patients with moderately to severely active ulcerative colitis: a protocol of systematic review and meta-analysis of placebo-controlled, randomised clinical trials
Compose a Response to This Article
Other responses
No responses have been published for this article.